In streptozotocin-treated adult male rats, the mechanisms of reduced response of testicular Leydig cells in vitro to stimulation with human chorionic gonadotropin was investigated. A decrease in testosterone formation by 70% after 6 weeks of diabetes mellitus is combined with diminished intracellular cyclic AMP accumulation as well as with a disturbance in progesterone conversion to androgens. The latter is also reflected by reduced progesterone binding to the cytochrome P-450 moiety of the steroid-17a-hydroxylase system.
Disturbances of spermatogenesis are well-known complications of diabetes mellitus in male patients, but there are only few and contradictory data concerning their hormonal state [1] .
Streptozotocin-induced diabetes mettitus in rats is frequently used as a model for studying late effects of the diabetic state. Among other complications, impairment of testicular function and fertility occurs in these diabetic animals: a spermatogenic arrest at step 7 spermatids was seen similar to that found in hypophysectomized animals [2] . Diminution of testicular androgen production in vivo as well as in vitro (incubation of interstitial cells) was described for streptozotocin-diabetic rats [3, 4] . This depression of endocrine testicular function was reported to be the consequence of the small amounts of luteinizing hormone releasing hormone (LHRH) secreted by the hypothalamus and of a reduction of blood lutropin (LH) levels [3] . Testicular functions and fertility could be improved by insulin treatment [4] and restored by means of a combined insulinhuman chorionic gonadotropin (HCG) therapy [5] .
The present study was undertaken to answer the question (1) can the probable loss of LH receptors on the surface of Leydig cells [6] alone explain diminished testosterone synthesis in testes from streptozotocindiabetic rats ? (2) are there additional disturbances within the steroidogenic pathways which could also be responsible for diabetic testicular injury?
Materials and Methods
Male Wistar rats, weighing 190-210 g at the beginning of the experiment, were used. Diabetes was induced by intraperitoneal injection of 100 mg streptozotocin/kg body weight (Calbiochem, GieBen, FRG; freshly prepared in 0.01 mol/l citrate buffer, pH 4.5). The diabetic state was verified by glucosuria 24 h later; venous blood levels of glucose were controlled at least twice weekly using the Ames reflectometer system. Animals exhibiting post prandial blood glucose levels < 3 g/1 were excluded from the diabetic group. In all other cases, duration of diabetes was 3 or 6 weeks as indicated. Control rats were given vehicle injection only. Animals were fed pelleted food and tap water ad libitum.
With this dose of streptozotocin, a 95% manifestation rate of hyperglycemia and glucosuria was achieved; mortality rate was 8% (n = 43). The body weight gain was + 1% in diabetic and + 30% in control animals during the first 3weeks; within 6weeks, body weight increased by 30% in the diabetic and by 56% in the control group.
The animals were killed by cervical dislocation; blood samples were collected by heart puncture for determination of serum testosterone levels, and the testes were removed immediately and weighed. For Leydig cell preparation, the decapsulated testes were incubated in collagenase solution (Boehringer Mannheim, FRG; 4 mg/testis) for 15 min at 33~ The desintegrated tissue was filtered through 60 gm nylon gauze and the cell suspensions were centrifuged at 80 x g for 10 min. Pellets were resuspended in Krebs-Ringer bicarbonate buffer, layered on top of two-step Percoll (Pharmacia, Freiburg, FRG) (original densities were 1.12 and 1.06 g/ml, respectively) centrifuged at 300 x g for 5 min. The Leydig cell fraction was collected by aspiration and washed twice by dilution in Eagle's minimum essential medium (MEM) with further centrifugation at 80 x g for 5 min. Cell contents in crude and purified suspensions were examined by counting 0. by distribution of non-specific esterase activity using p-rosaniline hydrochloride as a diazo coupling agent [7] .
Leydig cells were enriched from 10.2% in the crude suspensions to 87.7% by density gradient centrifugation. Recovery of intact Leydig cells (determined by enzymecytochemistry and the trypan blue exclusion test) was only 68% after this purification procedure.
In all experiments 2 x 105 Leydig cells were incubated in a final volume of 0.4 ml MEM at 33 ~ C in a shaking water bath for the times indicated. Testosterone production was measured after stimulation with 10-3g or 104g HCG/1 (Primogonyl, Schering, Berlin, FRG; all amounts referred to the second international standard for HCG) or with 0.2 or 2 mmol dibutyryl-cyclic AMP/1 (Boehringer Mannheim, FRG) by radioimmunoassay of ether extracts. Intracellular cyclic AMP was determined by a commercially available radioimmunoassay kit (Amersham Buchler, Braunschweig, FRG) after ultrasonic homogenization of cells and deproteinization by heating the samples.
For studies of steroidogenic pathways, cells were incubated in the presence of various amounts of either (4-14C-)pregnenolone (specific activity 55.7 mCi/mmol; New England Nuclear, Dreieich, FRG) or (4-14C-)progesterone (specific activity 36.1 mCi/mmol; Amersham Buchler, Braunschweig, FRG). Ether extracts were chromatographed twice on silica gel 60F254 plates in chloroform/ethylacetate (70/30, v/v). Steroid fractions were localized by autoradiography on X-ray films (Osray T4, Agfa-Gevaert) for 5 days, eluted with 15 ml dichloromethan/methanol (80/20, v/v), counted for radioactivity and corrected for 100% recovery. Identification and purity control of steroid fractions was performed by gas chromatography (Varian Series 1700, Varian MAT GmbH, Bremen, FRG) and mass spectrometry (Varian CH7A, Varian MAT GmbH, Bremen, FRG), using glass capillary column equipment (15m OV101, W.Gfinther Analysentechnik, Diisseldorf, FRG).
Since cytochrome P-450 is known to be the terminal oxidase in the steroid-17a-hydroxylase/17,20-1yase (EC 1.14.99.4/4.1.2.30) system [8] , binding of progesterone to this enzyme was measured by the method described in by Menard and Purvis [8] , using a Shimadzu UV300 spectrophotometer (Shimadzu Seisakusho, Kyoto, Japan). In brief, type I difference spectra (maximum at 390 nm, minimum at 420 nm) were induced by addition of various substrate concentrations to the sample cuvette. The absorbance differences (A390-A420nm) were plotted against substrate concentrations in a Lineweaver-Burk diagram. The maximal values of A390-A420nm represent maximal spectral effects of progesterone binding to cytochrome P-450.
Statistical analyses were carried out using Student's t-test; significance limit was 2 p < 0.05.
Results
Testicular weight was not altered during 6 weeks of streptozotocin-diabetes (3.06 + 0.06 g/two testes, mean + SEM, n = 22, in untreated and 3.08 _+ 0.15 g/two testes, n = 13, in diabetic animals). Yield of esterasepositive intact Leydig cells from one testis (after gradient centrifugation), however, was only 1.64 + 0.27 x 106 in diabetic but 3.22 + 0.29 x 106 in control rats (2p < 0.005). Plasma testosterone levels were 2.1 _+ 0.2 ng/ml in diabetic and 5.1 ___ 0.3 ng/ml in control rats (2p < 0.001).
Experiments in vitro with addition of 10 4 mol/1 streptozotocin demonstrated no significant decrease in basal or HCG-stimulated testosterone production of Leydig cells from control animals within 3 h.
Testosterone production of Leydig cells from normal rats was enhanced by a factor of 8.5 in the presence of 10 -6 g HCG/1 (Fig. 1 A) and by a factor of 17.2 by 10 .3 g HCG/1 (Fig. 1 B) compared with unstimulated control rats. However, if Leydig cells from 6 weeks diabetic animals were incubated in HCG-containing media, a significant decrease in testosterone production occurred with only 4.8-and 10.6-fold stimulation respectively ( Fig. 1 A and B) . Loss of HCG effects was apparently more distinct in cells obtained after 6 weeks than in those after 3 weeks of diabetes, although the differences were not significant at any time of incubation. The diabetic state did not affect significantly basal testosterone synthesis in vitro.
As can be seen from Figure 2A , the major effect of diabetes on Leydig cell testosterone response to HCG was manifest 3 weeks after streptozotocin treatment. Yet there was no significant reduction of Leydig cell cyclic AMP response to 103g HCG/1 in 3 week-old diabetic rats whereas a considerable diminution was observed until week 6 (Fig. 2 B) indicating a defect in mediation of HCG effects prior to the adenylate cyclase (pre-cyclic AMP lesion). Addition of 0.2 or 2 mmol dibutyryl-cyclic AMP/1 to diabetic Leydig cell suspensions revealed diminished stimulation of testosterone formation ( Fig. 2 C and D) indicating a cyclic AMP independent disturbance of testicular androgen biosynthesis. This effect (post-cyclic AMP lesion) was present within 3 weeks of induction of diabetes and only slightly more pronounced after 6 weeks. The ability of Leydig cells to metabolize progesterone, one of the precursors of androgen biosynthesis, to testosterone was also markedly reduced within 3 weeks of diabetes (Fig. 2 E) . It is thus obvious from Figure 2 that after induction of diabetes by streptozotocin, impairment of Leydig cell testosterone response to HCG and testosterone forma- fraction after thin-layer chromatography. In Leydig cells from the diabetic rats, a significant decrease of turnover of both steroids became evident in the presence of high pregnenolone and progesterone concentrations (Fig. 3) .
In an additional experiment, Leydig cells from normal and diabetic rats (6 weeks) were incubated with 750 pmol 14C-progesterone and changes of distribution of the activity in different steroid fractions were measured (Fig.4) . Progesterone activity disappeared from the medium significantly faster in control cells than in those from diabetic rats. Fifty percent of the initially added progesterone was metabolized within 10 min in control and 25 min in diabetic animals. Formation of 17a-hydroxyprogesterone reaches a maximal value at 15 min in control and at 60 min in diabetic groups. This retardation in testicular steroid biosynthesis was also seen in the androstenedione and testosterone fractions and indicated a decrease of steroid-17a-hydroxylase activity. Other steroid metabolites were found in the polar fraction in which 7a-hydroxytestosterone and 6fl-hydroxytestosterone could be identified. The sum of activity in those substances not shown in Figure 4 was significantly higher in incubations with control than with diabetic cells (2p < 0.05 at 120 min, 2p < 0.01 at 180 min) corresponding to the different testosterone levels.
Finally, there was a marked decrease in progesterone binding to cytochrome P-450 in isolated Leydig cell suspensions from 6 week-old diabetic rats: maximal progesterone-induced absorption differences per "10 6 purified Leydig cells were only 2.8 + 0.6 x "10 -4 versus 12.3 _+ "1.4 x "10 -4 in control cells (n = 4, 2p < 0.005).
Discussion
The loss of adequate steroidogenic response to HCG stimulation in interstitial cells from streptozotocin-diabetic rats is known from a previous work [4] but detailed time-course experiments have not yet been performed. In the present study constant amounts of isolated and highly purified Leydig cells were used and it was shown that the stimulatory effect of HCG is not only reduced in its extent but also occurs with a lag-time of about I h in cells from diabetic compared with cells from control rats (Fig. 1) . This pattern was obvious in the presence of either 106g HCG/1 (dose with nearly half-maximal effect) or 10-3g HCG/1 (about tenfold the dose with maximal effect).
The present experiments on Leydig cell function reveal that at least two steps in androgen biosynthesis may be disturbed in streptozotocin-diabetic rats: first, accumulation of cyclic AMP following application of HCG (pre-cyclic AMP lesion); second, conversion of steroid precursors to androgens (post-cyclic AMP lesion). The first lesion may be associated with reduced adenylate cyclase activity or with a diminution of HCG receptor number per interstitial cell [6] . Physical properties of these receptors do not change, and it has been suggested that alterations of carbohydrate metabolism may result in inactivation or modification of the receptor molecule [6] . The second lesion becomes evident from the reduced testosterone response to dibutyrylcyclic AMP. It seems noteworthy that the development of both disturbances during the course of diabetes is different (Fig.2B versus 2C-E) . The testosterone response to HCG ( Fig.2A) , which may be influenced by both lesions, develops in a similar manner as the postcyclic AMP defect (Fig.2C-E) . It is therefore possible that reduced HCG receptor number is of secondary importance for androgen biosynthesis.
The point of post-cyclic AMP lesion was investigated by means of steroid precursor conversion. Since differences in Leydig cell cholesterol turnover are difficult to determine because of the small amounts metabolized (about 2% in presence of HCG) only pregnenolone and progesterone turnover rates were measured and both were found to be markedly lower in diabetic than in control animals (Fig. 3) . If the decreased metabolism of pregnenolone reflects only the diminution in progesterone turnover or if there is an additional defect of the 4,5-isomerase system is not yet clear. In accordance with other authors [9, 10] , we could not detect any 17a-hydroxypregnenolone in the incubation media and therefore could rule out significant testosterone formation by the 5-ene pathway.
The decrease in progesterone turnover in Leydig cells from diabetic rats could be confirmed in the detailed time-course studies (Fig.4) . The distribution of the steroid activities at the individual times in the control experiments are comparable to the time-yield curves reported previously for progesterone turnover in rat testis interstitium [9] but develops somewhat slower than in isolated microsomes from the same tissue [11] . Based on the present results it can not be decided if, in addition to the conversion of progesterone to 17a-hydroxyprogesterone by the 17a-hydroxylase, activities of other enzymes involved in further metabolism to testosterone are also affected in diabetic animals. It should be mentioned that the experiments described in Figure 4 were all performed without addition of HCG because HCG does not influence significantly the turnover of a given progesterone pool (N. Ktihn-Velten, unpublished observation) but only affects liberation of free cholesterol and the cholesterol-pregnenolone conversion within the Leydig cell [12] .
The reduced binding of progesterone to Leydig cell cytochrome P-450, in connection with the fact that progesterone binding to the microsomal fraction of total testis homogenates is also reduced in diabetic animals [13] further supports the conclusion that the microsomal 17a-hydroxylase exhibits reduced activity after streptozotocin administration.
Since Leydig cell content in testes from streptozotocin-diabetic rats was markedly lower than in controls, the effects observed in the present study may be even greater in vivo. Impaired Leydig cell function in vivo is further reflected by the reduction of plasma testosterone levels in diabetic rats as has been already reported [3] . The differences observed between testicular function of normal and diabetic rats are probably not due to direct toxic effects of streptozotocin on Leydig cells as could be demonstrated by our studies in vitro.
The pathogenesis of the diabetic injury of testicular endocrine function is not yet understood. It has been claimed that impaired steroid synthesis in male diabetic rats is due to reduced activity of NADPH generating enzymes but even in the presence of high exogenous NADPH concentrations there still exist differences in testosterone release [4] . Another possible explanation may be a rise in testicular oestradiol concentrations; oestrogens have been suggested to play a possible role in the rise of testicular complications of diabetes mellitus [1] . A reduction of synthesis of enzyme proteins involved in testicular steroidogenesis due to insulin deficiency and a diminution of enzyme activities by glycosylation are other possible factors which must be taken into consideration.
Further investigations are necessary to answer the question, if there is a causal relationship between the loss of cyclic AMP response to HCG and the loss of steroid-17a-hydroxylase activity in Leydig cells from streptozotocin-diabetic rats and if these observations are reproducible in other animal models of diabetes mellitus.
